Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Prognostic Relevance of Steroid Sulfation in Adrenocortical Carcinoma Revealed by Molecular Phenotyping Using High-Resolution Mass Spectrometry Imaging.

Sun N, Kunzke T, Sbiera S, Kircher S, Feuchtinger A, Aichler M, Herterich S, Ronchi CL, Weigand I, Schlegel N, Waldmann J, Fragoso MCV, Whitsett TG, Gill AJ, Fassnacht M, Walch A, Kroiss M.

Clin Chem. 2019 Sep 6. pii: clinchem.2019.306043. doi: 10.1373/clinchem.2019.306043. [Epub ahead of print]

PMID:
31492715
2.

Driver mutations in USP8 wild type Cushing's disease.

Sbiera S, Perez-Rivas LG, Taranets L, Weigand I, Flitsch J, Graf E, Monoranu CM, Saeger W, Hagel C, Honegger J, Assie G, Hermus AR, Stalla GK, Herterich S, Ronchi CL, Deutschbein T, Reincke M, Strom TM, Popov N, Theodoropoulou M, Fassnacht M.

Neuro Oncol. 2019 Jun 19. pii: noz109. doi: 10.1093/neuonc/noz109. [Epub ahead of print]

PMID:
31222332
3.

Impact of USP8 Gene Mutations on Protein Deregulation in Cushing Disease.

Weigand I, Knobloch L, Flitsch J, Saeger W, Monoranu CM, Höfner K, Herterich S, Rotermund R, Ronchi CL, Buchfelder M, Glatzel M, Hagel C, Fassnacht M, Deutschbein T, Sbiera S.

J Clin Endocrinol Metab. 2019 Jul 1;104(7):2535-2546. doi: 10.1210/jc.2018-02564.

PMID:
30844069
4.

Enzyme autoinduction by mitotane supported by population pharmacokinetic modelling in a large cohort of adrenocortical carcinoma patients.

Arshad U, Taubert M, Kurlbaum M, Frechen S, Herterich S, Megerle F, Hamacher S, Fassnacht M, Fuhr U, Kroiss M.

Eur J Endocrinol. 2018 Oct 16;179(5):287-297. doi: 10.1530/EJE-18-0342.

PMID:
30087117
5.

LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy.

Rossow L, Veitl S, Vorlová S, Wax JK, Kuhn AE, Maltzahn V, Upcin B, Karl F, Hoffmann H, Gätzner S, Kallius M, Nandigama R, Scheld D, Irmak S, Herterich S, Zernecke A, Ergün S, Henke E.

Oncogene. 2018 Sep;37(36):4921-4940. doi: 10.1038/s41388-018-0320-2. Epub 2018 May 21.

6.

Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas.

Sbiera S, Tryfonidou MA, Weigand I, Grinwis GC, Broeckx B, Herterich S, Allolio B, Deutschbein T, Fassnacht M, Meij BP.

PLoS One. 2016 Dec 22;11(12):e0169009. doi: 10.1371/journal.pone.0169009. eCollection 2016.

7.

The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1.

Reuther C, Heinzle V, Nölting S, Herterich S, Hahner S, Halilovic E, Jeay S, Wuerthner JU, Aristizabal Prada ET, Spöttl G, Maurer J, Auernhammer CJ.

Neuroendocrinology. 2018;106(1):1-19. doi: 10.1159/000453369. Epub 2016 Nov 21.

PMID:
27871087
8.

Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.

Ronchi CL, Peverelli E, Herterich S, Weigand I, Mantovani G, Schwarzmayr T, Sbiera S, Allolio B, Honegger J, Appenzeller S, Lania AG, Reincke M, Calebiro D, Spada A, Buchfelder M, Flitsch J, Strom TM, Fassnacht M.

Eur J Endocrinol. 2016 Mar;174(3):363-72. doi: 10.1530/EJE-15-1064. Epub 2015 Dec 23.

PMID:
26701869
9.

On the role of NOS1 ex1f-VNTR in ADHD-allelic, subgroup, and meta-analysis.

Weber H, Kittel-Schneider S, Heupel J, Weißflog L, Kent L, Freudenberg F, Alttoa A, Post A, Herterich S, Haavik J, Halmøy A, Fasmer OB, Landaas ET, Johansson S, Cormand B, Ribasés M, Sánchez-Mora C, Ramos-Quiroga JA, Franke B, Lesch KP, Reif A.

Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):445-458. doi: 10.1002/ajmg.b.32326. Epub 2015 Jun 18.

PMID:
26086921
10.

Reciprocal regulation of human platelet function by endogenous prostanoids and through multiple prostanoid receptors.

Hubertus K, Mischnik M, Timmer J, Herterich S, Mark R, Moulard M, Walter U, Geiger J.

Eur J Pharmacol. 2014 Oct 5;740:15-27. doi: 10.1016/j.ejphar.2014.06.030. Epub 2014 Jul 6.

PMID:
25003953
11.

The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: further evidence and meta-analysis.

Weber H, Klamer D, Freudenberg F, Kittel-Schneider S, Rivero O, Scholz CJ, Volkert J, Kopf J, Heupel J, Herterich S, Adolfsson R, Alttoa A, Post A, Grußendorf H, Kramer A, Gessner A, Schmidt B, Hempel S, Jacob CP, Sanjuán J, Moltó MD, Lesch KP, Freitag CM, Kent L, Reif A.

Eur Neuropsychopharmacol. 2014 Jan;24(1):65-85. doi: 10.1016/j.euroneuro.2013.09.005. Epub 2013 Sep 27.

PMID:
24220657
12.

Soluble guanylyl cyclase is the only enzyme responsible for cyclic guanosine monophosphate synthesis in human platelets.

Gambaryan S, Subramanian H, Rukoyatkina N, Herterich S, Walter U.

Thromb Haemost. 2013 May;109(5):973-5. doi: 10.1160/TH12-12-0916. Epub 2013 Mar 7. No abstract available.

PMID:
23467662
13.

Association of a functional variant of the nitric oxide synthase 1 gene with personality, anxiety, and depressiveness.

Kurrikoff T, Lesch KP, Kiive E, Konstabel K, Herterich S, Veidebaum T, Reif A, Harro J.

Dev Psychopathol. 2012 Nov;24(4):1225-35. doi: 10.1017/S0954579412000661.

PMID:
23062293
14.

Frog urinary bladder epithelial cells express TLR4 and respond to bacterial LPS by increase of iNOS expression and L-arginine uptake.

Nikolaeva S, Bachteeva V, Fock E, Herterich S, Lavrova E, Borodkina A, Gambaryan S, Parnova R.

Am J Physiol Regul Integr Comp Physiol. 2012 Nov 15;303(10):R1042-52. doi: 10.1152/ajpregu.00045.2012. Epub 2012 Sep 26.

15.

[The Genetic Diagnostics Act. Instead of excitement and panic, rather a sensible strategy].

Bode C, Walter U, Tiede A, Herterich S.

Hamostaseologie. 2012;32(2):91-3. German. No abstract available.

PMID:
22696771
16.

Nuclear import of LASP-1 is regulated by phosphorylation and dynamic protein-protein interactions.

Mihlan S, Reiß C, Thalheimer P, Herterich S, Gaetzner S, Kremerskothen J, Pavenstädt HJ, Lewandrowski U, Sickmann A, Butt E.

Oncogene. 2013 Apr 18;32(16):2107-13. doi: 10.1038/onc.2012.216. Epub 2012 Jun 4.

PMID:
22665060
17.

Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD.

Weber H, Kittel-Schneider S, Gessner A, Domschke K, Neuner M, Jacob CP, Buttenschon HN, Boreatti-Hümmer A, Volkert J, Herterich S, Baune BT, Gross-Lesch S, Kopf J, Kreiker S, Nguyen TT, Weissflog L, Arolt V, Mors O, Deckert J, Lesch KP, Reif A.

Neuropsychopharmacology. 2011 Sep;36(10):2076-85. doi: 10.1038/npp.2011.98. Epub 2011 Jun 8.

18.

LOH and copy neutral LOH (cnLOH) act as alternative mechanism in sporadic colorectal cancers with chromosomal and microsatellite instability.

Melcher R, Hartmann E, Zopf W, Herterich S, Wilke P, Müller L, Rosler E, Kudlich T, Al-Taie O, Rosenwald A, Katzenberger T, Scholtka B, Seibold S, Rogoll D, Scheppach W, Scheurlen M, Lührs H.

Carcinogenesis. 2011 Apr;32(4):636-42. doi: 10.1093/carcin/bgr011. Epub 2011 Feb 4.

PMID:
21297112
19.

A novel BDNF polymorphism affects plasma protein levels in interaction with early adversity in rhesus macaques.

Cirulli F, Reif A, Herterich S, Lesch KP, Berry A, Francia N, Aloe L, Barr CS, Suomi SJ, Alleva E.

Psychoneuroendocrinology. 2011 Apr;36(3):372-9. doi: 10.1016/j.psyneuen.2010.10.019. Epub 2010 Dec 9.

20.

Association of a functional NOS1 promoter repeat with Alzheimer's disease in the VITA cohort.

Reif A, Grünblatt E, Herterich S, Wichart I, Rainer MK, Jungwirth S, Danielczyk W, Deckert J, Tragl KH, Riederer P, Fischer P.

J Alzheimers Dis. 2011;23(2):327-33. doi: 10.3233/JAD-2010-101491.

PMID:
21098972
21.

A functional NOS1 promoter polymorphism interacts with adverse environment on functional and dysfunctional impulsivity.

Reif A, Kiive E, Kurrikoff T, Paaver M, Herterich S, Konstabel K, Tulviste T, Lesch KP, Harro J.

Psychopharmacology (Berl). 2011 Mar;214(1):239-48. doi: 10.1007/s00213-010-1915-7. Epub 2010 Jun 30.

PMID:
20589495
22.

Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer.

Frietsch JJ, Grunewald TG, Jasper S, Kammerer U, Herterich S, Kapp M, Honig A, Butt E.

Br J Cancer. 2010 May 25;102(11):1645-53. doi: 10.1038/sj.bjc.6605685. Epub 2010 May 11.

23.

Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex.

Gambaryan S, Kobsar A, Rukoyatkina N, Herterich S, Geiger J, Smolenski A, Lohmann SM, Walter U.

J Biol Chem. 2010 Jun 11;285(24):18352-63. doi: 10.1074/jbc.M109.077602. Epub 2010 Mar 31.

24.

The effect of a functional NOS1 promoter polymorphism on impulsivity is moderated by platelet MAO activity.

Laas K, Reif A, Herterich S, Eensoo D, Lesch KP, Harro J.

Psychopharmacology (Berl). 2010 Apr;209(3):255-61. doi: 10.1007/s00213-010-1793-z. Epub 2010 Feb 26.

PMID:
20186396
25.

Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans.

Reif A, Jacob CP, Rujescu D, Herterich S, Lang S, Gutknecht L, Baehne CG, Strobel A, Freitag CM, Giegling I, Romanos M, Hartmann A, Rösler M, Renner TJ, Fallgatter AJ, Retz W, Ehlis AC, Lesch KP.

Arch Gen Psychiatry. 2009 Jan;66(1):41-50. doi: 10.1001/archgenpsychiatry.2008.510.

PMID:
19124687
26.

Disruption of the FA/BRCA pathway in bladder cancer.

Neveling K, Kalb R, Florl AR, Herterich S, Friedl R, Hoehn H, Hader C, Hartmann FH, Nanda I, Steinlein C, Schmid M, Tonnies H, Hurst CD, Knowles MA, Hanenberg H, Schulz WA, Schindler D.

Cytogenet Genome Res. 2007;118(2-4):166-76.

PMID:
18000367
27.

FZD3 is not a risk gene for schizophrenia: a case-control study in a Caucasian sample.

Reif A, Melchers M, Strobel A, Jacob CP, Herterich S, Lesch KP, Zimmer M.

J Neural Transm Suppl. 2007;(72):297-301.

PMID:
17982906
28.

Association of a NOS1 promoter repeat with Alzheimer's disease.

Galimberti D, Scarpini E, Venturelli E, Strobel A, Herterich S, Fenoglio C, Guidi I, Scalabrini D, Cortini F, Bresolin N, Lesch KP, Reif A.

Neurobiol Aging. 2008 Sep;29(9):1359-65. Epub 2007 Apr 6.

PMID:
17418914
29.

Analysis of SAGE data in human platelets: features of the transcriptome in an anucleate cell.

Dittrich M, Birschmann I, Pfrang J, Herterich S, Smolenski A, Walter U, Dandekar T.

Thromb Haemost. 2006 Apr;95(4):643-51.

PMID:
16601835
30.

Exclusion/confirmation of ataxia-telangiectasia via cell-cycle testing.

Heinrich T, Prowald C, Friedl R, Gottwald B, Kalb R, Neveling K, Herterich S, Hoehn H, Schindler D.

Eur J Pediatr. 2006 Apr;165(4):250-7. Epub 2006 Jan 13.

PMID:
16411093
31.

A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function.

Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, Wienker T, Töpner T, Fritzen S, Walter U, Schmitt A, Fallgatter AJ, Lesch KP.

Mol Psychiatry. 2006 Mar;11(3):286-300.

PMID:
16389274
32.

Understanding platelets. Lessons from proteomics, genomics and promises from network analysis.

Dittrich M, Birschmann I, Stuhlfelder C, Sickmann A, Herterich S, Nieswandt B, Walter U, Dandekar T.

Thromb Haemost. 2005 Nov;94(5):916-25. Review.

PMID:
16363231
33.

Prenatal exclusion/confirmation of Fanconi anemia via flow cytometry: a pilot study.

Bechtold A, Friedl R, Kalb R, Gottwald B, Neveling K, Gavvovidis I, Herterich S, Schindler D, Hoehn H.

Fetal Diagn Ther. 2006;21(1):118-24.

PMID:
16354989
34.

A NOS-III haplotype that includes functional polymorphisms is associated with bipolar disorder.

Reif A, Strobel A, Jacob CP, Herterich S, Freitag CM, Töpner T, Mössner R, Fritzen S, Schmitt A, Lesch KP.

Int J Neuropsychopharmacol. 2006 Feb;9(1):13-20. Epub 2005 Jun 21.

PMID:
15967063
35.

Lack of sensitivity of primary Fanconi's anemia fibroblasts to UV and ionizing radiation.

Kalb R, Duerr M, Wagner M, Herterich S, Gross M, Digweed M, Joenje H, Hoehn H, Schindler D.

Radiat Res. 2004 Mar;161(3):318-25.

PMID:
14982482
36.

Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport.

Reuter TY, Medhurst AL, Waisfisz Q, Zhi Y, Herterich S, Hoehn H, Gross HJ, Joenje H, Hoatlin ME, Mathew CG, Huber PA.

Exp Cell Res. 2003 Oct 1;289(2):211-21.

PMID:
14499622
37.

Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction.

Gross M, Hanenberg H, Lobitz S, Friedl R, Herterich S, Dietrich R, Gruhn B, Schindler D, Hoehn H.

Cytogenet Genome Res. 2002;98(2-3):126-35.

PMID:
12697994
38.

A mouse model for Sorsby fundus dystrophy.

Weber BH, Lin B, White K, Kohler K, Soboleva G, Herterich S, Seeliger MW, Jaissle GB, Grimm C, Reme C, Wenzel A, Asan E, Schrewe H.

Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2732-40.

PMID:
12147610
39.

Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast 2-hybrid system.

Reuter T, Herterich S, Bernhard O, Hoehn H, Gross HJ.

Blood. 2000 Jan 15;95(2):719-20.

40.

Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene.

Wijker M, Morgan NV, Herterich S, van Berkel CG, Tipping AJ, Gross HJ, Gille JJ, Pals G, Savino M, Altay C, Mohan S, Dokal I, Cavenagh J, Marsh J, van Weel M, Ortega JJ, Schuler D, Samochatova E, Karwacki M, Bekassy AN, Abecasis M, Ebell W, Kwee ML, de Ravel T, CG Mathew, et al.

Eur J Hum Genet. 1999 Jan;7(1):52-9.

41.

Site-specific mutagenesis in Enterobacter agglomerans: construction of nif B mutants and analysis of the gene's structure and function.

Siddavattam D, Nickles A, Herterich S, Steibl HD, Kreutzer R, Klingmüller W.

Mol Gen Genet. 1995 Dec 15;249(5):526-32.

PMID:
8544818
42.
43.

Analysis of retroorbital T cell antigen receptor variable region gene usage in patients with Graves' ophthalmopathy.

Heufelder AE, Herterich S, Ernst G, Bahn RS, Scriba PC.

Eur J Endocrinol. 1995 Mar;132(3):266-77.

PMID:
7889172

Supplemental Content

Loading ...
Support Center